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Inhibitory properties of 6E (compound 1) and 62 (compound 2) isomers of 2,3-epoxy-lo-aza-10.1 l-dihydrosqualene against oxrdosqualene- 
lanosterol cyclase were assayed on microsomes and whole cells of Saccharonzyces cerer~siae and Cundzdu albicans. Only the 6E isomer (compound 
1), bearing a correct substrate-like configuration, strongly inhibited the enzyme both m microsomes and cell cultures. The difference between 
compounds 1 and 2 (which had an unfavorable geometry) was especially evident when measuring [14C]acetate incorporation into non-saponifiable 
lipids extracted from treated cells. While isomer Z was totally ineffective at up to 30pM. in cells treated with 5pM isomer E. labelled oxtdosqualene, 
the level of which was negligible m the control, rose to over 60% of the non-saponifiable lipids. 
Oxidosqualene cyclase; Sterol biosynthesis inhtbitor; Saccharomyces cerewiae; Candida alhicans 
1. INTRODUCTION 
Enzymatic cyclization of 2,3-oxidosqualene into la- 
nosterol is a multistep process involving a series of tran- 
sient carbocationic high energy intermediates [l-3]. 
In the last few years, several successful attempts to 
inhibit oxidosqualene cyclizing enzymes. and several 
other enzymes involved in sterol or terpenoid biosyn- 
thesis, have been made by designing high energy inter- 
mediate analogues, bearing a stable positive charge at 
appropriate positions [4-81. Among the intermediate 
carbocations formed during enzymatic cyclization of 
oxidosqualene, the pro C-8 ion seemed to play a central 
role in the interaction between the substrate and the 
active site of the enzyme [9]. We therefore supposed that 
an oxidosqualene-like molecule such as (6E)-2,3-epoxy- 
lo-aza-10,l 1-dihydrosqualene (compound 1) (Fig. l), 
bearing a nitrogen group at the pro C-8 position, should 
behave as a high energy intermediate analogue and act 
as a powerful inhibitor of oxidosqualene cyclase. This 
molecule, belonging to the azasqualene series [6], would 
have the advantage in its interaction with the enzyme, 
both by the presence of an epoxide group at the end of 
the isoprenic skeleton and by the strict configurational 
resemblance (i.e. all trans squalenoid structure) with the 
substrate. This latter feature was, in our opinion, the 
essential requirement for the specific action of an 
azasqualene bearing the nitrogen group in the central 
part of the molecule. For this reason we decided to 
compare the inhibitory properties of the two isomers E 
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(compound 1) and Z (compound 2) of 2,3-epoxy-lo- 
aza-10,l 1 -dihydrosqualene (Fig. 1) against oxido- 
squalene cyclases in microsomes and in cell cultures of 
Cundida albicans and Saccharomyces cerevisiae. 
2. EXPERIMENTAL 
Compounds 1 and 2 were synthesized as reported [lo]. Synthesis of 
[“H]2.3-oxtdosqualene has also been descrtbed elsewhere [S]. Micro- 
somes from Saccharomyces cerevisroe (ATCC 12361) and Candidu 
alhicans were prepared by following a procedure previously described 
[I 11, except for the disruption of Cundida cells which was performed 
using a Dyno-mill (WAB) homogenizer. Microsomal oxidosqualene 
cyclase from both yeast strains was assayed as reported [1 11. Assay of 
sterol biosynthesis m whole cells of S. crrewslue and C. alhlcans by 
incubation with [2-14C]acetate, extraction of the non-saponifiable lip- 
Ids and separatton by thin layer chromatography has been reported 
171. 
‘“C radioactivity associated with different chromatographic bands 
was measured directly by scanning plates m a System 2000 Imagine 
Scanner (Packard), equipped with an MPM Computer. 
3. RESULTS 
Both the isomers 6E (compound 1) and 62 (com- 
pound 2) of 2,3-epoxy- 1 O-aza- 10.11 -dihydrosqualene 
failed to inhibit the growth of C. albicans, whereas their 
effect on S. cerevisiae was comparable with that re- 
ported for other aza-squalene derivatives [6,7] (Table I). 
The influence of compounds 1 and 2 on sterol biosyn- 
thesis was evaluated by incorporation of [14C]acetate 
into non-saponifiable lipids extracted from yeast cells 
cultured in the presence and in the absence of the inhib- 
itors (Tables II and III) (Fig. 3). Isomer E (compound 
1) caused a dose-dependent accumulation of radioactiv- 
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Fig. 1, 6E (compound 1) and 62 (compound 2) isomers of 2,3-epoxy-lo-aza-10.1 I-dihydrosqualene 
ity in oxidosqualene, accompanied by a sharp drop in 
the radioactivity incorporated into the 4,4-desmethyl 
sterol fraction (ergosterol fraction). In cultures of S. 
cerevisiue and C. albicans, the radioactivity associated 
with the oxidosqualene fraction, which was negligible in 
the controls, increased to represent over 60% of the 
non-saponifiable lipids in cells treated with 5 ,DM isomer 
E. The ergosterol fraction, which contained 70-80% of 
the radioactivity in the control cultures, fell to lo-20% 
in treated cells. Moreover, in C. ulbicuns. accumulation 
of radioactivity in the oxidosqualene fraction was ac- 
companied by the appearance of a fraction correspond- 
ing to dioxidosqualene. No increase in the radioactivity 
associated with the squalene fraction was noted, neither 
Table I 
Effect of isomer E and 2 on cell growth 
Isomer MIC (,uM) 
E 30 > 200 
Z 60 > 100 
in S. cerevisiue nor in C. ulbicans, by treatment of cells 
with isomer E at concentrations up to 60 PM. 
The two fungal strains responded differently to iso- 
mer Z (compound 2). In C. ulhicurrs, incorporation of 
radioactivity into components of the non-saponifiable 
fraction was not affected by exposure of cells to com- 
pound 2 at concentrations up to 30 ,uM (Table III). At 
higher concentrations the effect was similar to that pre- 
viously observed at lower concentrations of isomer E. 
i.e. an increase in the ratio of labelled oxidosqualene to 
labelled ergosterol. In S. cerevisiue the main response to 
isomer Z seemed to be a significant accumulation of 
radioactivity in a fraction co-chromatographing with 
lanosterol. a response quite similar to that reported 
after the treatment of cells with N,N-diethyldodecylam- 
ine [7]. 
A clear difference between the effects of isomer E and 
isomer Z was confirmed by results obtained with the 
microsomal oxidosqualene cyclase( s) from S. cerevisiue 
and C. alhicans. Only isomer E, which has a substrate- 
like conformation, was an effective inhibitor of ox- 
idosqualene cyclase from both sources (Table IV). As 
in the case of the assay on whole cells, microsomal 
oxidosqualene cyclases prepared from the two fungal 
strains responded differently to treatment with isomer 
Z. While the enzyme from S. cerevisiur was totally in- 
Table II 
Effect of isomer E and Z on mcorporation of [“Clacetate into non-sapondable liptd fractions m S ~~~PI~I.~Iu~ cells 
Concentrations 
of inhibitors 
@M) Ergosterol 
% total radioactivity mcorporated by 
Lanosterol Dioxidosqualene Oxidosqualene Squalene 
0 (control) 65 9 7.1 co.1 0.1 26.7 
Isomer E 5 16.’ 8.5 co 1 70.7 75 
Isomer E 10 2.6 co.1 co.1 87.5 9.9 
Isomer E 30 0.9 O.‘l co.1 86.6 10.1 
Isomer E 60 CO.1 0.2 <o 1 82.0 17.8 
Isomer Z 5 63 3 65 10.1 co.1 30.2 
Isomer Z 10 27.5 28.1 <o 1 6.6 37.8 
Isomer Z 30 39.1 18.8 10.1 8.5 23.5 
Isomer Z 60 27 7 25.2 co.1 27.3 19.7 
Results are means of 2 separate experiments each with duplicate mcubations. Maxtmum devtations from the mean were less than 10%. 
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Fig. 2. Radtochromatograms of non-sapomfiable lipids extracted from cells of S cerrvislue incubated with [‘JC]acetate for 2 h. (a) Cells incubated 
without Inhibitors. (b) Cells exposed to 5 PM Isomer E (compound 1) durmg the mcubation ttme. The markers from left to right were: ergosterol. 
lanosterol, dtoxtdoaqualene, oxtdosqualene and squalene. 
Table III 
Effect of isomer E and 2 on incorporatton of l”Clacetate into non-saponifiable hptd fracttons in C. alh~a~s cells 
Concentrations 8 total radtoacttvity incorporated by 
of inhibitors 
WM) Ergosterol Lanoaterol Dioxidosqualene Oxtdosqualene Squalene 
0 (control) 86.3 1.4 co.1 6.2 6.1 
Isomer E 5 23.1 3.8 4.1 65.1 2.7 
Isomer E 30 7.1 2.6 5.6 80.3 4.3 
Isomer E 60 4.9 3.2 4.3 79 3 8.3 
Isomer Z 30 83.2 5.8 co. I 7.1 3.7 
Isomer Z 60 30.3 6.9 3.0 53.6 6.2 
Results are means of 2 separate experiments each wtth duphcate Incubations. Maximum devtations from the mean were less than 10% 
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Table IV 
I,, values WM) of inhlbition of mlcrosomal oxldosqualene cyclase by 
isomer E and Z 
Isomer s cerel’rslur c. crlblcarls 
E 5 3 
Z > 200 > 50 
Results are means of two separate experiments. Microsomal protein 
concentration was 3 mg/ml for S cerer,slae and 3 mg/ml for C albl- 
CLIIIS. I,,, values were determmed at a substrate concentratton of 25 
PM. K,,, of oxidosqualene cyclase from S ~E~CKSI(I~ was 34 ? 8 PM 
(mean + SD for five separate experrments) [7]. 
sensitive to the inhibitor. the enzyme from C. ulbicans 
was weakly inhibited. 
4. DISCUSSION 
Results obtained with (6E)-lo-azasqualene (com- 
pound 1) on microsomes and whole cells of S. cerevisiue 
and C. ulbicuns indicate that this approach represents 
a new step in the strategy for designing azasqualene 
derivatives as inhibitors of fungal oxidosqualene 
cyclase. This inhibitor, which was designed as an ana- 
logue of the pro C-8 high energy intermediate formed 
during transformation of oxidosqualene into lanosterol, 
is the most powerful and specific of the azasqualenes 
tested so far [6,7.12,13]. This conclusion is based, in 
particular, on the experiments with whole cells, in which 
a dramatic accumulation of oxidosqualene occurred in 
the presence of (6E)-lo-azasqualene at concentrations 
at which other azasqualene derivatives are inactive. 
The inhibitory properties of (6E)-lo-azasqualene 
might be due to the presence on the inhibitor molecule 
of a stable positive charge at a position (pro C-8) which 
is thought to strongly interact with the active site of the 
enzyme [5,9]. Moreover, the compound also has a 2,3- 
epoxide group, which increases its similarity to the sub- 
strate and may favor enzyme-inhibitor recognition. 
Squalene epoxidase does not seem to be affected by 
the inhibitor. Neither in S. cerevisiue nor in C. ulbicans 
did treatment of cells with (6E)-lo-azasqualene (com- 
pound 1) induce any accumulation of squalene in non- 
saponifiable lipids. 
The difference in inhibitory activity between the 6E 
and 62 isomers of lo-azasqualene provides direct evi- 
dence of the dependence of activity on structural simi- 
larity with the substrate. The Z isomer, which has an 
unfavorable geometry, did not significantly affect the 
sterol biosynthesis at up to 30 ,uM in whole cells, nor 
did it significantly inhibit oxidosqualene cyclase in mi- 
crosomes. In S. cerevisiue, the inhibitory activity of iso- 
mer Z appeared to affect other enzymes of sterol bio- 
synthesis, as indicated by the increase of the lanosterol 
fraction in treated cells. 
In conclusion, our work supports the view that 
azasqualenes bearing the nitrogen group in the central 
part of the isoprenic skeleton, need a correct all tram 
configurational geometry to specifically inhibit fungal 
oxidosqualene cyclase. Azasqualenes having different 
geometrical structures, such as (6Z)-2,3-epoxy-lo-aza- 
10, I-dihydrosqualene. do not have the specific ability to 
inhibit oxidosqualene cyclase; other enzymes of sterol 
biosynthesis seem, in this case. to become targets of 
their action. It can be supposed that the presence of a 
stable positive charge within the isoprenic skeleton ena- 
bles the 62 isomer to affect enzymes like d8-.4’-sterol 
isomerase and di4-sterol reductase. which catalyze reac- 
tions that also involve high energy intermediate carbo- 
cations. Similar inhibitory properties have been re- 
ported for azadecaline derivatives, which inhibit Ax-d’- 
isomerase, in addition to oxidosqualene cyclase [12]. 
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